Postdoctoral Fellow Binita Chakraborty, PhD was intrigued: in published analyses of large numbers of patients with melanoma (skin cancer) treated with an immunotherapy that is becoming standard of care, the treatment worked better in men than in women.

Turning a Terrifying Ordeal into an Opportunity to Help

When reports early last winter indicated that a mysterious new infectious disease had broken out of its point of origin in Wuhan, China, Charles Lucore, MD’83, P’17, MBA, began to prepare for its possible arrival in New York.

Twin 9-year-old girls at Duke Health became the first in the United States to participate in a Pfizer and BioNTech Phase 1 study to evaluate safety, tolerability and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine in preventing COVID-19 among healthy children below the age of 12.

A surgical team expands the reach of Duke’s cardiovascular care to bring lifesaving treatment to patients with few other options.

As far back as Donna Bernstein can remember, the ethos of giving back has been as much a part of her as her name or the color of her eyes. She comes from strong Jewish roots, and her parents instilled in her and her sister and three brothers the Jewish principle that everyone has a responsibility to help others through charity and service.

Young dancer conquers rare, debilitating disease and now trains among the world's elite.

After more than half a century and millions of dollars raised to support student scholarships in the Duke University School of Medicine and School of Nursing, the Nearly New Shoppe thrift store ceased operations at the end of August 2020.

In late July, while on their 2020 summer break, Duke Club Cycling riders launched a 12-hour bike marathon to support Duke Health’s COVID-19 Response Funds and local cycling organizations that advocate for cycling as an alternative and safer form of transportation.

In 1983, Duke University alumnus Ross Harris, had just lost her younger brother, Carlton Harris Jr., to leukemia. He was only 25.